Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial.
Orly VardenyJames C FangAkshay S DesaiPardeep S JhundBrian ClaggettMuthiah VaduganathanRudolf A de BoerAdrian F HernandezCarolyn Su Ping LamSilvio E InzucchiFelipe A MartinezMikhail Naum KosiborodDavid DeMetsEileen O'MearaShelley ZierothJosep Comín ColetJarosław DrożdżChern-En ChiangMasafumi KitakazeMagnus PeterssonDaniel LindholmAnna Maria LangkildeJohn Joseph Valentine McMurrayScott D SolomonPublished in: Nature medicine (2023)
Keyphrases
- ejection fraction
- heart failure
- aortic stenosis
- phase iii
- study protocol
- phase ii
- clinical trial
- left ventricular
- cardiac resynchronization therapy
- acute heart failure
- atrial fibrillation
- randomized controlled trial
- open label
- coronary artery disease
- transcatheter aortic valve replacement
- double blind
- placebo controlled